205 related articles for article (PubMed ID: 31703329)
1. Baicalein as a Potential Inhibitor against BACE1 and AChE: Mechanistic Comprehension through In Vitro and Computational Approaches.
Han J; Ji Y; Youn K; Lim G; Lee J; Kim DH; Jun M
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31703329
[TBL] [Abstract][Full Text] [Related]
2. In Silico Docking and In Vitro Approaches towards BACE1 and Cholinesterases Inhibitory Effect of Citrus Flavanones.
Lee S; Youn K; Lim G; Lee J; Jun M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29932100
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of β-site amyloid precursor protein cleaving enzyme 1 and cholinesterases by pterosins via a specific structure-activity relationship with a strong BBB permeability.
Jannat S; Balupuri A; Ali MY; Hong SS; Choi CW; Choi YH; Ku JM; Kim WJ; Leem JY; Kim JE; Shrestha AC; Ham HN; Lee KH; Kim DM; Kang NS; Park GH
Exp Mol Med; 2019 Feb; 51(2):1-18. PubMed ID: 30755593
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
[TBL] [Abstract][Full Text] [Related]
5. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides.
Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA
J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774
[TBL] [Abstract][Full Text] [Related]
6. Flavanone glycosides inhibit β-site amyloid precursor protein cleaving enzyme 1 and cholinesterase and reduce Aβ aggregation in the amyloidogenic pathway.
Ali MY; Jannat S; Edraki N; Das S; Chang WK; Kim HC; Park SK; Chang MS
Chem Biol Interact; 2019 Aug; 309():108707. PubMed ID: 31194956
[TBL] [Abstract][Full Text] [Related]
7. Dual BACE1 and Cholinesterase Inhibitory Effects of Phlorotannins from
Lee J; Jun M
Mar Drugs; 2019 Feb; 17(2):. PubMed ID: 30717208
[TBL] [Abstract][Full Text] [Related]
8. Kinetics and molecular docking of dihydroxanthyletin-type coumarins from Angelica decursiva that inhibit cholinesterase and BACE1.
Ali MY; Seong SH; Jung HA; Jannat S; Choi JS
Arch Pharm Res; 2018 Jul; 41(7):753-764. PubMed ID: 30047040
[TBL] [Abstract][Full Text] [Related]
9. From AChE to BACE1 inhibitors: The role of the amine on the indanone scaffold.
Rampa A; Mancini F; De Simone A; Falchi F; Belluti F; Di Martino RM; Gobbi S; Andrisano V; Tarozzi A; Bartolini M; Cavalli A; Bisi A
Bioorg Med Chem Lett; 2015 Jul; 25(14):2804-8. PubMed ID: 26003339
[TBL] [Abstract][Full Text] [Related]
10. Dynamic Simulation, Docking and DFT Studies Applied to a Set of Anti-Acetylcholinesterase Inhibitors in the enzyme β-Secretase (BACE-1): An Important Therapeutic Target in Alzheimer`s disease.
Silva-Junior EF; Barcellos Franca PH; Quintans-Junior LJ; Mendonca-Junior FJB; Scotti L; Scotti MT; de Aquino TM; de Araujo-Junior JX
Curr Comput Aided Drug Des; 2017 Nov; 13(4):266-274. PubMed ID: 28382866
[TBL] [Abstract][Full Text] [Related]
11. Identification of embelin, a 3-undecyl-1,4-benzoquinone from Embelia ribes as a multitargeted anti-Alzheimer agent.
Nuthakki VK; Sharma A; Kumar A; Bharate SB
Drug Dev Res; 2019 Aug; 80(5):655-665. PubMed ID: 31050027
[TBL] [Abstract][Full Text] [Related]
12. Kinetics and molecular docking studies of loganin, morroniside and 7-O-galloyl-D-sedoheptulose derived from Corni fructus as cholinesterase and β-secretase 1 inhibitors.
Bhakta HK; Park CH; Yokozawa T; Min BS; Jung HA; Choi JS
Arch Pharm Res; 2016 Jun; 39(6):794-805. PubMed ID: 27106028
[TBL] [Abstract][Full Text] [Related]
13. Bioactive polycyclic polyprenylated acylphloroglucinols from Hypericum perforatum.
Guo Y; Zhang N; Sun W; Duan X; Zhang Q; Zhou Q; Chen C; Zhu H; Luo Z; Liu J; Li XN; Xue Y; Zhang Y
Org Biomol Chem; 2018 Nov; 16(43):8130-8143. PubMed ID: 30334059
[TBL] [Abstract][Full Text] [Related]
14. Identification of aplysinopsin as a blood-brain barrier permeable scaffold for anti-cholinesterase and anti-BACE-1 activity.
Nuthakki VK; Yadav Bheemanaboina RR; Bharate SB
Bioorg Chem; 2021 Feb; 107():104568. PubMed ID: 33418314
[TBL] [Abstract][Full Text] [Related]
15. Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents.
Galdeano C; Viayna E; Arroyo P; Bidon-Chanal A; Blas JR; Muñoz-Torrero D; Luque FJ
Curr Pharm Des; 2010; 16(25):2818-36. PubMed ID: 20698824
[TBL] [Abstract][Full Text] [Related]
16. Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels.
Youn K; Yu Y; Lee J; Jeong WS; Ho CT; Jun M
Nutrients; 2017 Sep; 9(9):. PubMed ID: 28869548
[TBL] [Abstract][Full Text] [Related]
17. 1,3,5-Triazine Nitrogen Mustards with Different Peptide Group as Innovative Candidates for AChE and BACE1 Inhibitors.
Maliszewski D; Wróbel A; Kolesińska B; Frączyk J; Drozdowska D
Molecules; 2021 Jun; 26(13):. PubMed ID: 34203347
[TBL] [Abstract][Full Text] [Related]
18. Molecular insights into the inhibitory mechanism of bi-functional bis-tryptoline triazole against β-secretase (BACE1) enzyme.
Narang SS; Goyal D; Goyal B
Amino Acids; 2019 Nov; 51(10-12):1593-1607. PubMed ID: 31654211
[TBL] [Abstract][Full Text] [Related]
19. Dual-target compounds for Alzheimer's disease: Natural and synthetic AChE and BACE-1 dual-inhibitors and their structure-activity relationship (SAR).
Ferreira JPS; Albuquerque HMT; Cardoso SM; Silva AMS; Silva VLM
Eur J Med Chem; 2021 Oct; 221():113492. PubMed ID: 33984802
[TBL] [Abstract][Full Text] [Related]
20. New Benzamides as Multi-Targeted Compounds: A Study on Synthesis, AChE and BACE1 Inhibitory Activity and Molecular Docking.
Drozdowska D; Maliszewski D; Wróbel A; Ratkiewicz A; Sienkiewicz M
Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]